HealthTronics' OssaTron Lithotripter PMA Submission Will Focus On Heel Pain
This article was originally published in The Gray Sheet
HealthTronics says it expects to submit a premarket approval application to FDA for the OssaTron orthopedic lithotripter by the end of the summer.
You may also be interested in...
A premarket approval application for HealthTronics' OssaTron lithotripter for treatment of chronic heel pain due to planar fasciitis should be submitted to FDA by December.
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.